Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. forodesine hydrochloride (BCX-1777)

   Biocryst

   Leukemia, T-Cell

   phase 2 · small molecule · completed

   1 trial →

2. forodesine hydrochloride (BCX-1777)

   Biocryst

   B-cell Acute Lymphoblastic Leukemia

   phase 2 · small molecule · completed

   1 trial →

3. fostamatinib

   RIGEL PHARMACEUTICALS INC

   Lymphoma

   phase 2 · small molecule · completed

   1 trial →

4. fruquintinib

   Takeda

   Colon Cancer

   phase 2 · small molecule · active

   1 trial →

5. furmonertinib

   Sun Yat-sen University

   Non-small Cell Lung Cancer Metastatic

   phase 2 · small molecule · completed

   1 trial →

6. ganetespib

   United Therapeutics Europe Ltd

   Malignant Peripheral Nerve Sheath Tumors (MPNST)

   phase 2 · small molecule · completed

   1 trial →

7. gemcitabine

   Yung NA

   Muscle Invasive Bladder Urothelial Carcinoma

   phase 2 · small molecule · active

   1 trial →

8. gemcitabine and cisplatin

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Nasopharyngeal Squamous Cell Carcinoma

   phase 2 · small molecule · completed

   1 trial →

9. gemcitabine and oxaliplatin.

   The First People's Hospital of Lianyungang

   Gallbladder Carcinoma

   phase 2 · small molecule · active

   1 trial →

10. genexolPM + cisplatin

    Solid Biosciences

    Locally Advanced Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

11. hyperbaric oxygen

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

12. imvotamab

    ADC Therapeutics SA

    Non-Hodgkin Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

13. indibulin

    Alaunos Therapeutics

    Advanced Solid Tumors

    phase 2 · small molecule · active

    2 trials →

14. infusion of MYOCET

    Teva Pharma GmbH

    Cerebral Lymphoma B Cell Refractory

    phase 2 · small molecule · terminated

    1 trial →

15. inhaled delta-8-THC 300mcg or 600mcg per dose

    Teva Pharma GmbH

    Cancer

    phase 2 · small molecule · terminated

    1 trial →

16. interleukin-4 PE38KDEL cytotoxin

    NEUROCRINE BIOSCIENCES INC

    Brain and Central Nervous System Tumors

    phase 2 · mab · completed

    1 trial →

17. intravenous infusion (IV) of Adebrelimab (ADE)

    The First People's Hospital of Lianyungang

    Advanced Hepatocellular Carcinoma (HCC)

    phase 2 · small molecule · active

    1 trial →

18. ipatasertib

    United Therapeutics Europe Ltd

    Solid Tumor

    phase 2 · small molecule · active

    1 trial →

19. irradiation

    Ultragenyx UK Limited

    Brain Neoplasms

    phase 2 · other · active

    1 trial →

20. ivosidenib and nivolumab

    Agios Netherlands B.V.

    Advanced Solid Tumor

    phase 2 · small molecule · completed

    1 trial →

21. lenalidomide combined with rituximab

    The First People's Hospital of Lianyungang

    Diffuse Large B Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

22. lurbinectedin for Advanced/Recurrent Endometrial…

    The George Institute

    Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy

    phase 2 · small molecule · active

    1 trial →

23. lymphokine-activated killer cells

    LISATA THERAPEUTICS, INC.

    Brain and Central Nervous System Tumors

    phase 2 · mab · terminated

    1 trial →

24. mFOLFOX6 + BIBF 1120

    Galmed Pharmaceuticals

    Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

25. mFOLFOXIRI

    The First People's Hospital of Lianyungang

    Locally Advanced Rectal Cancer

    phase 2 · small molecule · active

    1 trial →

26. mRNA-4157, BCG VACCINE

    Merck Sharp and Dohme

    Bladder cancer

    phase 2 · small molecule · active

    1 trial →

27. megestrol acetate oral suspension + serplulimab + SOX

    The First People's Hospital of Lianyungang

    Stage III Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

28. mitoxantrone liposome 16 and azacitidine

    NovaBridge Biosciences

    Angioimmunoblastic T-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

29. nab-paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

30. nal-IRI /Experimental

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Gastric Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

31. nanoliposomal irinotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head & Neck Cancer

    phase 2 · small molecule · completed

    1 trial →

32. nanoparticle albumin-bound paclitaxel/carboplatin

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

33. nedaplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Central Nervous System Tumors

    phase 2 · small molecule · active

    1 trial →

34. neoadjuvant anti-PD-1

    Shanghai Chest Hospital

    Esophageal Cancer

    phase 2 · small molecule · active

    1 trial →

35. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2-mutant Non-Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

36. neratinib

    PUMA BIOTECHNOLOGY, INC.

    Breast Neoplasms

    phase 2 · small molecule · completed

    3 trials →

37. nilotinib

    United Therapeutics Europe Ltd

    Mucosal Lentiginous Melanoma

    phase 2 · small molecule · completed

    1 trial →

38. nivolumab

    Bristol-Myers Squibb

    Neoplasms by Site

    phase 2 · mab · completed

    1 trial →

39. nivolumab, ipilimumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 · small molecule · completed

    1 trial →

40. oncolytic adenovirus expressing GMCSF

    CG Oncology

    Bladder Cancer

    phase 2 · mab · terminated

    1 trial →

41. ondansetron

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma (HCC)

    phase 2 · small molecule · active

    1 trial →

42. online adaptive radiotherapy

    The First People's Hospital of Lianyungang

    Cervical Cancer

    phase 2 · other · active

    1 trial →

43. orelabrutinib combined with rituximab regimen

    The First People's Hospital of Lianyungang

    Marginal Zone Lymphoma(MZL)

    phase 2 · small molecule · active

    1 trial →

44. osimertinib

    AstraZeneca

    Carcinoma

    phase 2 · small molecule · active

    1 trial →

45. osimertinib mesylate tablets and anlotinib hydrochloride capsules

    The First People's Hospital of Lianyungang

    Non Small Cell Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

46. oxaliplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stomach Neoplasms

    phase 2 · small molecule · active

    1 trial →

47. pCAR-19B cells

    Chongqing Precision Biotech Co., Ltd

    Acute Lymphoblastic Leukemia

    phase 2 · mab · active

    2 trials →

48. pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine

    United Therapeutics Europe Ltd

    Anatomic Stage I Breast Cancer AJCC v8

    phase 2 · mab · active

    1 trial →

Frequently asked questions